» Articles » PMID: 12973924

Mechanism of Three Inhibitors of TACE in Blocking the Converting of Pro-TNF Alpha into STNF Alpha

Overview
Specialty General Medicine
Date 2003 Sep 17
PMID 12973924
Authors
Affiliations
Soon will be listed here.
Abstract

The effects of inhibitors of TNF alpha converting enzyme (TACE) on TNF alpha secretion were studied to develop an approach to interfere inflammation processes. The HL-60 cell lines were stimulated in vitro with LPS intravenously for different time to establish the cellular model of inflammation and simultaneously induce in vivo inflammation animal model by LPS The cytotoxic effects of soluble TNF alpha were checked using MTT colorimetric method to determine the rate of cell proliferation. The level of expression of TACE was detected by using RT-PCR, FCM and immuno-histochemical technique respectively. It was found Chinese medicine Reduqing (RDQ) could inhibit the transcription of TNF alpha mRNA induced by LPS stimulation (P < 0.01, compared with the control). The antioligodeoxyribonucleotide (anti-ODN) of TNF alpha mRNA could inhibit 78.9% of TNF alpha secretion. The mimic peptides of TACE substrates with hydroxamine group showed potency in vivo and in vitro against converting of pro-TNF alpha. It was concluded that all the three types of TACE inhibitors can regulate the expression of TACE at different levels and inhibit sTNF alpha secretion, indicating TACE is a novel target for inflammation therapy.

References
1.
Black R, Rauch C, Kozlosky C, Peschon J, Slack J, Wolfson M . A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature. 1997; 385(6618):729-33. DOI: 10.1038/385729a0. View

2.
Black R, Durie F, Miller R, Slack J, Lynch D, Castner B . Relaxed specificity of matrix metalloproteinases (MMPS) and TIMP insensitivity of tumor necrosis factor-alpha (TNF-alpha) production suggest the major TNF-alpha converting enzyme is not an MMP. Biochem Biophys Res Commun. 1996; 225(2):400-5. DOI: 10.1006/bbrc.1996.1186. View

3.
Takashiba S, Van Dyke T, Shapira L, Amar S . Lipopolysaccharide-inducible and salicylate-sensitive nuclear factor(s) on human tumor necrosis factor alpha promoter. Infect Immun. 1995; 63(4):1529-34. PMC: 173185. DOI: 10.1128/iai.63.4.1529-1534.1995. View

4.
Amin A . Regulation of tumor necrosis factor-alpha and tumor necrosis factor converting enzyme in human osteoarthritis. Osteoarthritis Cartilage. 1999; 7(4):392-4. DOI: 10.1053/joca.1998.0221. View

5.
Flick D, Gifford G . Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J Immunol Methods. 1984; 68(1-2):167-75. DOI: 10.1016/0022-1759(84)90147-9. View